Concepedia

Qidi Ying

QY

6

Publications

213

Citations

6

H-Index

2017

Active since

Affiliations

The University of Western Australia(Current)

Royal Perth Hospital

University of New England

China Pharmaceutical University

Qidi Ying is an author at The University of Western Australia specializing in immunology, inflammation, and atherosclerosis.

ORCID

Top concepts

Publications per year

2017–2023

6

Publications

6

Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment

Qian Yu, Minda Zhang, Qidi Ying et al. · Cell Death and Disease · 2019 · 97 citations · Full text

PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)

Gerald F. Watts, Dick C. Chan, Jing Pang et al. · Metabolism · 2020 · 67 citations

, , +12

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration

Qidi Ying, Dick C. Chan, Jing Pang et al. · Journal of Internal Medicine · 2022 · 14 citations

G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE −/− mice

Lifen Qian, Lingman Ma, Guanzhong Wu et al. · Vascular Pharmacology · 2017 · 13 citations

, , +9

Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?

Natalie C. Ward, Qidi Ying, Dick C. Chan et al. · Journal of clinical lipidology · 2023 · 12 citations · Full text

Rows per page

1–5 of 6